CompletedNot Applicable

Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

United States792 participantsStarted 2012-07

Plain-language summary

The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs;
✓. \> 40mg of diazepam (or diazepam equivalents) in 1 hr; or
✓. an individual dose of 40 mg or greater of intravenous diazepam for control of agitation

Identify those risk factors predictive of benzodiazepine-resistant alcohol withdrawal syndrome

Timeframe: up to 38 months

NCT IDNCT01652326

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-09